Encompass Health initiated with an Equal Weight at Barclays. Barclays analyst Patrick Feeley started Encompass Health with an Equal Weight rating and $75 price target. The company should continue to benefit from its development program, but shares fully discount the opportunity at present, Feeley tells investors in a research note.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.